Classical primary hyperparathyroidism—a disease of ... and who show no evidence of a secondary hyperparathyroid state, such as vitamin D deficiency, renal insufficiency, marked hypercalciuria ...

Cinacalcet is a calcimimetic indicated to treat secondary hyperparathyroidism in patients with end-stage CKD on dialysis. 38 It is also indicated as a treatment for primary hyperparathyroidism and ...

There are three possible explanations for the pathogenesis of hyperparathyroidism in this case. The first is that it may have been primary parathyroid hyperplasia with secondary chronic renal disease.

7 The primary pathogenic factors for secondary hyperparathyroidism are increased phosphate retention and low calcitriol levels, which worsen with progressive loss of renal function. High phosphate ...

BACKGROUND: Normohormonal primary hyperparathyroidism presents diagnostic and intraoperative challenges, and current literature is conflicting about management. We aim to better define ...

Some data support use of calcimimetics to manage predialysis secondary hyperparathyroidism, hypercalcemic hyperparathyroidism in kidney graft recipients, primary hyperparathyroidism and ...

Occasionally, a clinical state of secondary hyperparathyroidism manifested by osteitis fibrosa and metastatic calcification develops. Although autonomous parathyroid hyperfunction has been ...

Various endocrine disorders can compromise bone health, such as long-term diabetes, thyrotoxicosis, hypogonadism, vitamin D ...